0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

THE VALUE OF EXPERIMENTAL STUDY OF TRANSPLANTABLE TUMORS.

JAMA. 1903;XLI(5):317-318. doi:10.1001/jama.1903.04480020025014.
Text Size: A A A
Published online

The study of malignant tumors by the usual methods hitherto in vogue has not yielded many results of fundamental importance. A serious drawback to this study is encountered in the non-inoculability of human tumors in animals. The occurrence in certain animals of transplantable tumors furnishes the investigator with welcome opportunities to institute various lines of experimentation looking, for instance, to the production of immunizing and curative substances. Thus Jensen2 of Copenhagen was able to work with an inoculable, spontaneous tumor in a white mouse. He has carried the experimental inoculation through nineteen generations, and other experiments have been made with a view to producing active as well as passive immunity—at the same time as the tumor cells have been subjected to various procedures calculated to throw some light on their properties. This tumor occurred originally subcutaneously, and was in structure a carcinoma, which character it subsequently maintained. Subcutaneous injections

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();